US Phase I/II clinical trials and discontinuation of NS-018
An individual drug development theme concerning NS-018, for which Phase I/II trials were conducted in the United States and Phase II trials overseas, ultimately leading to the discontinuation of development.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.